Life-style intervention

BEHAVIORAL3 trials

Sponsors

Tokyo University, Soroka University Medical Center, Novartis Pharmaceuticals

Conditions

Childhood ObesityDiabetes MellitusGlucose IntoleranceMetabolic SyndromePsoriasis

Phase 4

Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT)

CompletedNCT00301392

Tokyo UniversityDiabetes Mellitus, Glucose Intolerance

Start: 2006-04-30End: 2012-06-30Updated: 2013-09-06

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

CompletedNCT03440736

Novartis PharmaceuticalsMetabolic Syndrome, Psoriasis

Start: 2018-02-28End: 2022-06-03Updated: 2026-04-22

Unknown Phase

The Impact of the Nutrition Enrichment and Healthy Living Model ( NEHLM) on Diet Quality, Physical Activity and Dental Health Among Children From Socioeconomically Disadvantaged Families in Beer Sheva

Soroka University Medical CenterChildhood Obesity

Start: 2008-09-30End: 2011-09-30Updated: 2010-02-19

Related Papers

Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients.

2019-10-1055 citations

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01